ID CP142_MYCS2 Reviewed; 401 AA. AC A0R4Q6; DT 18-JAN-2017, integrated into UniProtKB/Swiss-Prot. DT 09-JAN-2007, sequence version 1. DT 27-MAR-2024, entry version 116. DE RecName: Full=Steroid C26-monooxygenase {ECO:0000303|PubMed:23489718}; DE EC=1.14.15.28 {ECO:0000269|PubMed:23489718, ECO:0000305|PubMed:25210044}; DE AltName: Full=Cholest-4-en-3-one C26-monooxygenase {ECO:0000303|PubMed:23489718}; DE AltName: Full=Cholest-4-en-3-one C26-monooxygenase [(25R)-3-oxocholest-4-en-26-oate forming] {ECO:0000303|PubMed:23489718}; DE AltName: Full=Cholesterol C26-monooxygenase {ECO:0000303|PubMed:23489718}; DE AltName: Full=Cholesterol C26-monooxygenase [(25R)-3beta-hydroxycholest-5-en-26-oate forming] {ECO:0000303|PubMed:23489718}; DE AltName: Full=Cytochrome P450 142 {ECO:0000303|PubMed:23489718}; DE AltName: Full=Steroid C27-monooxygenase {ECO:0000250|UniProtKB:P9WPL5}; GN Name=cyp142 {ECO:0000303|PubMed:23489718}; GN Synonyms=cyp142A2 {ECO:0000303|PubMed:23489718}; GN OrderedLocusNames=MSMEG_5918 {ECO:0000312|EMBL:ABK74975.1}; OS Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) (Mycobacterium OS smegmatis). OC Bacteria; Actinomycetota; Actinomycetes; Mycobacteriales; Mycobacteriaceae; OC Mycolicibacterium. OX NCBI_TaxID=246196; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 700084 / mc(2)155; RA Fleischmann R.D., Dodson R.J., Haft D.H., Merkel J.S., Nelson W.C., RA Fraser C.M.; RL Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases. RN [2] RP X-RAY CRYSTALLOGRAPHY (1.69 ANGSTROMS) OF 4-401 IN COMPLEX WITH HEME, RP FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, RP DISRUPTION PHENOTYPE, INDUCTION, SUBSTRATE SPECIFICITY, AND PATHWAY. RC STRAIN=ATCC 700084 / mc(2)155; RX PubMed=23489718; DOI=10.1111/1462-2920.12108; RA Garcia-Fernandez E., Frank D.J., Galan B., Kells P.M., Podust L.M., RA Garcia J.L., Ortiz de Montellano P.R.; RT "A highly conserved mycobacterial cholesterol catabolic pathway."; RL Environ. Microbiol. 15:2342-2359(2013). RN [3] RP X-RAY CRYSTALLOGRAPHY (1.78 ANGSTROMS) IN COMPLEX WITH HEME, FUNCTION, RP CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND COFACTOR. RX PubMed=25210044; DOI=10.1074/jbc.m114.602771; RA Frank D.J., Madrona Y., Ortiz de Montellano P.R.; RT "Cholesterol ester oxidation by mycobacterial cytochrome P450."; RL J. Biol. Chem. 289:30417-30425(2014). CC -!- FUNCTION: Involved in the utilization of cholesterol as the sole carbon CC and energy source by degrading the side chain. Primarily catalyzes the CC sequential oxidation of the terminal methyl of cholest-4-en-3-one into CC (25R)-26-hydroxycholest-4-en-3-one (alcohol), (25R)-26-oxocholest-4-en- CC 3-one (aldehyde), to finally yield the carboxylic acid (25R)-3- CC oxocholest-4-en-26-oate. Also able to sequentially oxidize cholesterol CC itself, not only cholest-4-en-3-one. {ECO:0000269|PubMed:23489718, CC ECO:0000269|PubMed:25210044}. CC -!- CATALYTIC ACTIVITY: CC Reaction=cholest-4-en-3-one + 5 H(+) + 3 O2 + 6 reduced [2Fe-2S]- CC [ferredoxin] = (25R)-3-oxocholest-4-en-26-oate + 4 H2O + 6 oxidized CC [2Fe-2S]-[ferredoxin]; Xref=Rhea:RHEA:49996, Rhea:RHEA-COMP:10000, CC Rhea:RHEA-COMP:10001, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:15379, ChEBI:CHEBI:16175, ChEBI:CHEBI:33737, CC ChEBI:CHEBI:33738, ChEBI:CHEBI:71570; EC=1.14.15.28; CC Evidence={ECO:0000269|PubMed:23489718, ECO:0000305|PubMed:25210044}; CC -!- COFACTOR: CC Name=heme; Xref=ChEBI:CHEBI:30413; CC Evidence={ECO:0000269|PubMed:23489718, ECO:0000269|PubMed:25210044}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=10.3 uM for cholest-4-en-3-one {ECO:0000269|PubMed:23489718}; CC KM=39.8 uM for cholesteryl sulfate {ECO:0000269|PubMed:25210044}; CC -!- PATHWAY: Steroid metabolism; cholesterol degradation. CC {ECO:0000303|PubMed:23489718}. CC -!- INDUCTION: By cholesterol. {ECO:0000269|PubMed:23489718}. CC -!- DISRUPTION PHENOTYPE: Cells lacking this gene show a slight reduction CC in the levels of cholest-4-en-3-one-26-oate, but the concentration of CC 26-hydroxycholest-4-en-3-one is not measurably affected. The levels of CC 26-hydroxycholest-4-en-3-one and cholest-4-on-3-one-26-oate are CC drastically reduced in cells lacking both cyp125A3 and cyp142A2. CC {ECO:0000269|PubMed:23489718}. CC -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; CP000480; ABK74975.1; -; Genomic_DNA. DR RefSeq; WP_011730892.1; NZ_SIJM01000017.1. DR RefSeq; YP_890144.1; NC_008596.1. DR PDB; 2YOO; X-ray; 1.69 A; A/B/C/D=4-401. DR PDB; 3ZBY; X-ray; 1.93 A; A/B/C/D/E/F=1-401. DR PDB; 4TRI; X-ray; 2.00 A; A/B=1-401. DR PDB; 4UAX; X-ray; 1.78 A; A=1-401. DR PDBsum; 2YOO; -. DR PDBsum; 3ZBY; -. DR PDBsum; 4TRI; -. DR PDBsum; 4UAX; -. DR AlphaFoldDB; A0R4Q6; -. DR SMR; A0R4Q6; -. DR STRING; 246196.MSMEG_5918; -. DR PaxDb; 246196-MSMEI_5758; -. DR GeneID; 66737205; -. DR KEGG; msm:MSMEG_5918; -. DR PATRIC; fig|246196.19.peg.5758; -. DR eggNOG; COG2124; Bacteria. DR OrthoDB; 5241086at2; -. DR BRENDA; 1.14.15.28; 3512. DR UniPathway; UPA01058; -. DR Proteomes; UP000000757; Chromosome. DR GO; GO:0020037; F:heme binding; IEA:InterPro. DR GO; GO:0005506; F:iron ion binding; IEA:InterPro. DR GO; GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW. DR GO; GO:0016705; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; IEA:InterPro. DR GO; GO:0006707; P:cholesterol catabolic process; IEA:UniProtKB-UniPathway. DR CDD; cd11033; CYP142-like; 1. DR Gene3D; 1.10.630.10; Cytochrome P450; 1. DR InterPro; IPR001128; Cyt_P450. DR InterPro; IPR002397; Cyt_P450_B. DR InterPro; IPR017972; Cyt_P450_CS. DR InterPro; IPR036396; Cyt_P450_sf. DR PANTHER; PTHR46696; P450, PUTATIVE (EUROFUNG)-RELATED; 1. DR PANTHER; PTHR46696:SF1; P450, PUTATIVE (EUROFUNG)-RELATED; 1. DR Pfam; PF00067; p450; 1. DR PRINTS; PR00359; BP450. DR PRINTS; PR00385; P450. DR SUPFAM; SSF48264; Cytochrome P450; 1. DR PROSITE; PS00086; CYTOCHROME_P450; 1. PE 1: Evidence at protein level; KW 3D-structure; Cholesterol metabolism; Heme; Iron; Lipid degradation; KW Lipid metabolism; Metal-binding; Monooxygenase; NADP; Oxidoreductase; KW Reference proteome; Steroid metabolism; Sterol metabolism. FT CHAIN 1..401 FT /note="Steroid C26-monooxygenase" FT /id="PRO_0000438724" FT BINDING 343 FT /ligand="heme" FT /ligand_id="ChEBI:CHEBI:30413" FT /ligand_part="Fe" FT /ligand_part_id="ChEBI:CHEBI:18248" FT /note="axial binding residue" FT /evidence="ECO:0000269|PubMed:23489718, FT ECO:0000269|PubMed:25210044, ECO:0007744|PDB:2YOO, FT ECO:0007744|PDB:3ZBY, ECO:0007744|PDB:4TRI, FT ECO:0007744|PDB:4UAX" FT HELIX 15..19 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 23..33 FT /evidence="ECO:0007829|PDB:2YOO" FT STRAND 35..38 FT /evidence="ECO:0007829|PDB:2YOO" FT STRAND 44..46 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 49..57 FT /evidence="ECO:0007829|PDB:2YOO" FT TURN 59..61 FT /evidence="ECO:0007829|PDB:2YOO" FT STRAND 62..64 FT /evidence="ECO:0007829|PDB:2YOO" FT STRAND 70..72 FT /evidence="ECO:0007829|PDB:4UAX" FT HELIX 78..80 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 85..93 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 94..96 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 99..103 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 106..121 FT /evidence="ECO:0007829|PDB:2YOO" FT STRAND 124..127 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 128..131 FT /evidence="ECO:0007829|PDB:2YOO" FT TURN 132..134 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 135..145 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 149..151 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 152..163 FT /evidence="ECO:0007829|PDB:2YOO" FT STRAND 168..170 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 172..198 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 204..209 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 220..235 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 238..251 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 253..261 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 263..265 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 266..277 FT /evidence="ECO:0007829|PDB:2YOO" FT STRAND 282..289 FT /evidence="ECO:0007829|PDB:2YOO" FT STRAND 291..293 FT /evidence="ECO:0007829|PDB:2YOO" FT STRAND 296..298 FT /evidence="ECO:0007829|PDB:2YOO" FT STRAND 303..307 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 308..311 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 315..318 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 339..341 FT /evidence="ECO:0007829|PDB:2YOO" FT HELIX 346..363 FT /evidence="ECO:0007829|PDB:2YOO" FT STRAND 368..371 FT /evidence="ECO:0007829|PDB:2YOO" FT STRAND 381..383 FT /evidence="ECO:0007829|PDB:2YOO" FT STRAND 390..392 FT /evidence="ECO:0007829|PDB:2YOO" SQ SEQUENCE 401 AA; 44901 MW; 9195ECA2F9D8D509 CRC64; MTQMLTRPDV DLVNGMFYAD GGAREAYRWM RANEPVFRDR NGLAAATTYQ AVLDAERNPE LFSSTGGIRP DQPGMPYMID MDDPQHLLRR KLVNAGFTRK RVMDKVDSIG RLCDTLIDAV CERGECDFVR DIAAPLPMAV IGDMLGVLPT ERDMLLKWSD DLVCGLSSHV DEAAIQKLMD TFAAYTEFTK DVITKRRAEP TDDLFSVLVN SEVEGQRMSD DEIVFETLLI LIGGDETTRH TLSGGTEQLL RHRDQWDALV ADVDLLPGAI EEMLRWTSPV KNMCRTLTAD TVFHGTELRA GEKIMLMFES ANFDESVFGD PDNFRIDRNP NSHVAFGFGT HFCLGNQLAR LELRLMTERV LRRLPDLRLA DDAPVPLRPA NFVSGPESMP VVFTPSAPVL A //